TissGeneSummary for DYNAP |
Gene summary |
Basic gene information | Gene symbol | DYNAP |
Gene name | dynactin associated protein | |
Synonyms | C18orf26 | |
Cytomap | UCSC genome browser: 18q21.2 | |
Type of gene | protein-coding | |
RefGenes | NM_173629.1, | |
Description | dynactin-associated proteinfull | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000178690 | ||
HPRD : 08251 | ||
Vega : OTTHUMG00000132709 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DYNAP | |
BioGPS: 284254 | ||
Pathway | NCI Pathway Interaction Database: DYNAP | |
KEGG: DYNAP | ||
REACTOME: DYNAP | ||
Pathway Commons: DYNAP | ||
Context | iHOP: DYNAP | |
ligand binding site mutation search in PubMed: DYNAP | ||
UCL Cancer Institute: DYNAP | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Esophagus | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | ESCA | |
Reference showing the relevant tissue of DYNAP | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0008284 | positive regulation of cell proliferation | 20978158 | GO:0032148 | activation of protein kinase B activity | 20978158 | GO:0042981 | regulation of apoptotic process | 20978158 | GO:1901625 | cellular response to ergosterol | 20978158 | GO:0008284 | positive regulation of cell proliferation | 20978158 | GO:0032148 | activation of protein kinase B activity | 20978158 | GO:0042981 | regulation of apoptotic process | 20978158 | GO:1901625 | cellular response to ergosterol | 20978158 |
Top |
TissGeneExp for DYNAP |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for DYNAP |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for DYNAP |
TissGeneSNV for DYNAP |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.S141L | SKCM | 3 |
p.S198F | SKCM | 2 |
p.P167S | SKCM | 2 |
p.E95K | SKCM | 2 |
p.W112* | SKCM | 1 |
p.M27T | LIHC | 1 |
p.T196S | HNSC | 1 |
p.L63V | ESCA | 1 |
p.E42K | SKCM | 1 |
p.W61X | LIHC | 1 |
p.G140E | SKCM | 1 |
p.W16X | SKCM | 1 |
p.S89L | SKCM | 1 |
p.W16* | SKCM | 1 |
p.H209Y | SKCM | 1 |
p.G23V | LUAD | 1 |
p.D52N | SKCM | 1 |
p.T207A | LUAD | 1 |
p.L86F | SKCM | 1 |
p.M111R | SKCM | 1 |
p.S177L | SKCM | 1 |
p.G84E | SKCM | 1 |
p.L119F | SKCM | 1 |
p.Q149* | SKCM | 1 |
p.E42X | THYM | 1 |
p.S65* | LUAD | 1 |
p.D28N | SKCM | 1 |
p.W61* | LIHC | 1 |
p.S58F | SKCM | 1 |
p.Q53E | LUAD | 1 |
p.W112X | SKCM | 1 |
Top |
TissGeneCNV for DYNAP |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for DYNAP |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for DYNAP |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for DYNAP |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for DYNAP |
TissGeneDrug for DYNAP |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for DYNAP |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |